Dexcom

Dexcom, Inc. is a prominent medical technology company founded in 1999, specializing in the development and manufacturing of continuous glucose monitoring (CGM) systems for individuals managing diabetes. Its devices provide real-time glucose data for effective health management. With a commitment to advancing diabetes care globally, Dexcom focuses on enhancing accuracy, reliability, and user experience. The company operates from its headquarters in San Diego, California. Learn about Dexcom's global headquarters for detailed location information.

The company's product portfolio centers on its cutting-edge CGM technology, including systems that provide predictive alerts and seamless connectivity. Dexcom's devices are designed for precision and ease of use, supporting a wide range of users from pediatric to adult populations. With an employee range exceeding 10,000 individuals and operations spanning 24 locations globally, Dexcom demonstrates significant operational scale. Innovation is evident in next-gen solutions and Clarity software, aiding clinical analysis. Meet Dexcom's team to understand the expertise driving these advancements.

Dexcom generates substantial revenue, reporting $4.66B in its latest financial disclosures. The company has a history of strategic funding rounds, including significant share placements and venture capital investments, underscoring investor confidence in its growth trajectory. Its competitive landscape includes major players in the diabetes care and medical device sectors such as Insulet, Medtronic Diabetes, and Abbott Diabetes Care. Dexcom's market presence is marked by product evolution and dedication to improving quality of life for people with diabetes. Explore financial highlights for a deeper dive into their fiscal performance.